Microdosing magic mushrooms has grown in popularity in recent years, and early research is beginning to examine both its potential benefits and its limits. Anecdotal reports often describe mood improvements, reduced anxiety, or enhanced focus, but the largest placebo-controlled study to date (Szigeti et al., 2021) found that many of these effects may be driven by expectation rather than the substance itself. Microdosing is not right for everyone and carries real risks for some populations — this article looks at what current research does and does not support.
Who Might Benefit from Microdosing Magic Mushrooms?
Microdosing magic mushrooms is not suitable for everyone, and the scientific evidence for therapeutic benefit is still limited. Small doses of psilocybin and psilocin do not produce the full psychedelic experience, and some users report improvements in mood, focus, or emotional openness.
Early studies and anecdotal reports suggest microdosing may be of interest to people dealing with:
- Mild depressive symptoms
- Social anxiety
- Chronic stress
- Creative blocks
Importantly, microdosing is contraindicated for people with:
- Bipolar disorder (risk of manic episodes)
- Psychotic disorders or a personal/family history of psychosis
- Severe anxiety disorders
- Concurrent use of SSRIs or other serotonergic medications (risk of serotonin syndrome)
- Certain cardiac conditions
Anyone considering microdosing should first consult a qualified clinician.
“Psychedelics prove to you that there’s more than one way of seeing the world.”
Is Microdosing Magic Mushrooms Legal?
Magic mushrooms are still illegal in much of the world, although the restrictions are not really enforced in most places as long as people are not too open about their use. Magic mushrooms have been decriminalized in certain American cities, including:
- Seattle, Washington
- Oakland, California
- Denver, Colorado
- Ann Arbor, Michigan
- Santa Cruz, California
- Cambridge, Massachusetts
- Somerville, Massachusetts
- Washington, D.C., which is especially significant since D.C. is often the “testing grounds” for policies later written into national law.
Still, the illegality and resulting negative associations with magic mushrooms in many places remain the largest obstacles to the widespread acceptance of microdosing in the therapeutic community. The good news is that the tide is turning, especially in the past few years. Some places, like California, Oregon, The Netherlands, Brazil, Jamaica, and The Bahamas, have decriminalized psilocybin-containing drugs for therapeutic use in a controlled setting. Of course, even in those countries you should check with a professional to ensure you’re microdosing in a legal way. Other states and countries are expected to follow soon.
Large organizations like the FDA have issued statements that magic mushrooms are not addictive or dangerous, and many experts believe that before long they will experience the same gradual legalization process that cannabis is currently going through.
Pros and Cons of Microdosing Magic Mushrooms
Microdosing psilocybin is associated with a range of self-reported positive effects, though responses vary considerably between individuals and the placebo-controlled evidence base remains limited. It doesn’t carry with it the risk of having a “bad trip” like a full dose of mushrooms does, since the dosage is too small to cause feelings that are overwhelmingly negative. Of course, it does have its downsides, too. Let’s look at some of the most notable pros and cons.
Pros
The following benefits are drawn from self-report surveys and early observational research — controlled trials are still limited. Pros include:
- Enhanced cognitive function
- Increased creativity levels
- Sharper focus when studying, working, etc.
- Reduction in depression and anxiety
- Increased self-confidence
- Improved mood and outlook on life
- Promotes healthier habits and routines
- Enhanced self-insight and mindfulness
- Heightened perception and awareness
- Improved interpersonal relationships
- Easy to administer, although measuring the dosage can be a hassle.
- Not habit-forming, a sentiment reflected by the FDA.
- Lack of any notable side effects (usually, see below)
Interest in these effects has placed microdosing among the more closely watched areas in psychedelic research, though it has not yet been validated as a standard pharmaceutical treatment.
Cons
The cons list is shorter than the list of pros, but some of the cons may be deal-breakers for some people. Also, remember that some of the cons may be non-existent for certain individuals while they pose larger problems for others. They include:
- Adverse physical effects, such as heightened heart rate.
- Problems with measuring out the correct dosage. A precision scale helps with this.
- Anxiety about acquiring an illegal substance, especially in regards to sourcing or quality.
- Increased anxiety
- Residual tiredness
- Concern about developing dependence
Most of these cons are either unfounded or can be mitigated by microdosing magic mushrooms in the presence of a licensed therapist that specializes in psilocybin, especially your first few times. And, best of all, the cons will more than likely be corrected in the commercially available microdosing options we are sure to see in the future.
Microdosing Mushrooms: Clinical Trials
The clinical trials for microdosing mushrooms are generally divided into three main types: naturalistic studies, placebo-controlled studies, and controlled lab studies. Let’s take a look at the benefits and drawbacks of each.
| Naturalistic | Naturalistic-Controlled | Controlled | |
| What is it? | Testers seek out people who say they have been microdosing for a while and give them questionnaires to gauge their experiences. | Testers find individuals to do a pre-prepared dosage at home and then call them into a lab for tests to gauge the effects they’ve been experiencing. | Testers call a carefully-selected group of participants into a lab and give them a measured dose at the same time, then observe all participants in a controlled setting. |
| Pros | Very inexpensive, with a larger sample possible. People can take a personalized dosage amount that is best for them. Participants are more at ease. | Participants are at ease, but testers still know exactly what type of microdose they’ve been taking. Relatively inexpensive. | Participants are tested for drug use and other conditions. It’s the best way to do repeated tests for things like effects of microdosing at a certain time of day, with less “noise.” |
| Cons | Cannot restrict alcohol use or other substances that might interfere with microdosing effects. Participants may be untruthful. | The pre-prepared dosage amount may not be just right for everyone (e.g. a large man and a small woman may have different optimal dosages). | Relatively expensive. Participants’ experiences may be negatively affected by anxiety from being “under a microscope” |
The Findings
The effects of microdosing mushrooms have been documented in literally hundreds of studies. Until quite recently, the vast majority of study results were only documented through humanistic methods like surveys and questionnaires, though. Although surveys are still a part of most studies, the methods used to gather data from participants in microdosing studies have grown a lot more quantitative during this decade.
Many modern microdosing studies include cutting-edge methods like EEGs, blood test analyses, and heart rate monitoring. These advanced methods have resulted in a gigantic amount of knowledge gained about the effects of microdosing in the past few years. Small changes in mood or changes in consciousness that would have gone unreported before are now observable. In other words, test-givers are now able to monitor even the smallest effects caused by microdosing, and that allows them to get a better idea of how it can impact you.
This ability to gauge the effects of different types of magic mushroom doses with such precision is a huge leap forward in making microdosing more accessible. One of the biggest issues with microdosing in the past is that even the experts could not pinpoint exactly what effects it might have for different types of people. Thanks to recent developments in the techniques used to gather findings, that issue is rapidly becoming a thing of the past.
How to Find Microdosing Studies Near Me
It’s easy to find studies looking at the effects of psilocybin that are recruiting new participants in places where the drug is decriminalized. Most of the participants are volunteers (unpaid), but some studies pay a small amount. Some great resources for finding microdosing studies near you include: John Hopkins Center for Psychedelic and Consciousness Research (US) Psychedelic.support (US) Mind Medicine Australia (AUS) MAPS Clinical Trials (Worldwide) Note that these pages also recruit for studies focusing on other psychedelics, like MDMA and LSD, as well as cannabis.
Legitimate microdosing studies are very hard to come by in Europe. In August 2022, Clerkenwell Health, the world’s first commercial firm dedicated to psychedelics research, opened in London. In the future, they plan to conduct lots of large-scale clinical trials that will recruit local volunteers.
If you are unable to find a microdosing study near you online, it cannot hurt to ask your doctor or therapist if they know of any such studies during one of your sessions (where you will be protected by doctor-patient confidentiality, if you’re worried about that).
The Future of Microdosing Magic Mushrooms
There is not much question that magic mushrooms, among other psilocybin-containing drugs, are on a fast-track to wider acceptance and legalization, at least in a clinical capacity. Interest in psychedelic medicine is growing, with clinical trials exploring their potential for depression, anxiety, and other conditions. However, it is too early to call psychedelics a replacement for established treatments — head-to-head comparisons against existing pharmaceuticals are limited, and the largest microdosing trial to date did not show benefits above placebo.
Although taking full doses of psychedelics can be a very intense experience, microdosing is the perfect way to enjoy the huge range of positives with almost imperceptible versions of the negatives to go with them. And as more and more research is done on the precise effects of microdosing different types of magic mushrooms, the experience will become even more streamlined and easier to obtain in convenient-to-administer forms. Eventually, buying and microdosing magic mushrooms will probably be as easy as doing the same thing with antidepressants or painkillers is now.
The clinical trial pipeline for psilocybin is now the most active it has been since the 1960s. Landmark Phase 3 results from COMPASS Pathways, published in early 2026, have moved the conversation from proof-of-concept to regulatory consideration.
The next few years of psychedelic drug research will look to answer questions like:
- Will people develop a biological tolerance to certain psychedelics after taking them repeatedly for long enough?
- How will microdosing interact with certain traits (e.g. age, sex, weight, personality, sleep receptor binding)?
- How can we continue to fight the negative misconceptions surrounding most psychedelics?
These are the questions the next wave of clinical trials will answer.
Dustin Kemp
· Updated
